Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients

References

• Holst-Schumacher I, Nunez-Rivas H, Monge-Rojas R . Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren. Food Nutr Bull. 2009;30(2):161–70.
   PubMedGoogle Scholar
• Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004;33(2):351–75.
   PubMedGoogle Scholar
• Gomez M, Ramirez M, Disdier O. Prevalence of the metabolic syndrome among a determined Puerto Rican population. P R Health Sci J. 2006;25(2):111–6.
   PubMedGoogle Scholar
• Berenson GS, Srinivasan SR. Cholesterol as a risk factor for early atherosclerosis: the Bogasula Heart Study. N. Engl. J. Med. 1998;338:1650–6.
   PubMed Web of Science ®Google Scholar
• Bokor S, Frelut ML, Vania A . Prevalence of metabolic syndrome in European obese children. Int J Pediatr Obes. 2008;3 Suppl 2:3–8.
   Web of Science ®Google Scholar
• Zimmet P, Alberti G, Kaufman F . The metabolic syndrome in children and adolescents. Lancet. 2007; 369 (9579): 2059–61.
   PubMed Web of Science ®Google Scholar
• Brambilla P, Lissau I, Flodmark CE . Metabolic risk-factor clustering estimation in children: to draw a line across pediatric metabolic syndrome. Int J Obes (Lond). 2007; 31(4):591–600.
   PubMed Web of Science ®Google Scholar
• Pennacchio LA, Olivier M, Hubacek JA . An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001;294 (5540):169–73.
   PubMedGoogle Scholar
• Aouizerat BE, Kulkarni M, Heilbron D . Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. J Lipid Res. 2003;44(6):1167–73.
   PubMedGoogle Scholar
• Pennacchio LA, Olivier M, Hubacek JA . Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet. 2002;11(24):3031–8.
   PubMedGoogle Scholar
• Havasi V, Szolnoki Z, Talian G . Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke. J Mol Neurosci. 2006;29(2):177–83.
   PubMed Web of Science ®Google Scholar
• Szalai C, Keszei M, Duba J . Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis. 2004;173(1):109–14.
   PubMedGoogle Scholar
• Yamada Y, Kato K, Hibino T . Prediction of genetic risk for metabolic syndrome. Atherosclerosis. 2007;191(2): 298–304.
   PubMedGoogle Scholar
• Moreno-Luna R, Perez-Jimenez F, Marin C . Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population. J Clin Endocrinol Metab. 2007;92(6):2280–5.
   PubMedGoogle Scholar
• Kisfali P, Mohas M, Maasz A . Haplotype analysis of the apolipoprotein A5 gene in patients with metabolic syndrome. Nutr Metab Cardiovasc Dis. 2009 Aug 17. [Epub ahead of print].
   PubMedGoogle Scholar
• Endo K, Yanagi H, Araki J . Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren. Hum Genet. 2002;111(6):570–2.
   PubMedGoogle Scholar
• Cole TJ, Bellizzi MC, Flegal KM . Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320(7244):1240–3.
   PubMed Web of Science ®Google Scholar
• Elosua R, Ordovas JM, Cupples LA . Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study. J Lipid Res. 2006;47(5):990–6.
   PubMedGoogle Scholar
• Chen ES, Furuya TK, Mazzotti DR . APOA1/A5 Variants and Haplotypes as a Risk Factor for Obesity and Better Lipid Profiles in a Brazilian Elderly Cohort. Lipids. 2010; 45(6):511–7.
   PubMedGoogle Scholar
• Meigs JB, Rutter MK, Sullivan LM . Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care. 2007;30(5):1219–25.
   PubMedGoogle Scholar
• Moreno LA, Pineda I, Rodriguez G . Waist circumference for the screening of the metabolic syndrome in children. Acta Paediatr. 2002;91(12):1307–12.
   PubMedGoogle Scholar
• Bloom SR, Kuhajda FP, Laher I . The obesity epidemic: pharmacological challenges. Mol Interv. 2008;8(2):82–98.
   PubMedGoogle Scholar
• Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415–28.
   PubMedGoogle Scholar
• Freedman DS, Dietz WH, Srinivasan SR . The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999; 103(6 Pt 1):1175–82.
   PubMedGoogle Scholar
• Molnar D. The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents. Int J Obes Relat Metab Disord. 2004;28 Suppl 3:S70–4.
   PubMed Web of Science ®Google Scholar
• Vanhala M, Vanhala P, Kumpusalo E . Relation between obesity from childhood to adulthood and the metabolic syndrome: population based study. BMJ. 1998;317 (7154):319.
   PubMedGoogle Scholar
• Barkai L, Paragh G. [Metabolic syndrome in childhood and adolescence]. Orv Hetil. 2006;147(6):243–50.
   PubMedGoogle Scholar
• Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol. 2000;86(9): 943–9.
   PubMedGoogle Scholar
• van der Vliet HN, Sammels MG, Leegwater AC . Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem. 2001;276(48): 44512–20.
   PubMedGoogle Scholar
• Grallert H, Sedlmeier EM, Huth C . APOA5 variants and metabolic syndrome in Caucasians. J Lipid Res. 2007; 48(12):2614–21.
   PubMedGoogle Scholar
• Kisfali P, Mohas M, Maasz A . Apolipoprotein A5 IVS3+476A allelic variant associates with increased trigliceride levels and confers risk for development of metabolic syndrome in Hungarians. Circ J. 2008;72(1):40–3.
   PubMedGoogle Scholar
• Maasz A, Kisfali P, Horvatovich K . Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome. Pathol Oncol Res. 2007;13(3):243–7.
   PubMedGoogle Scholar
• Aristimuno GG, Foster TA, Voors AW . Influence of persistent obesity in children on cardiovascular risk factors: the Bogalusa Heart Study. Circulation. 1984;69(5):895–904.
   PubMedGoogle Scholar
• Weiss R, Dziura J, Burgert TS . Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362–74.
   PubMed Web of Science ®Google Scholar
• Martinelli N, Trabetti E, Bassi A . The -1131 T > C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study. Atherosclerosis. 2007;191(2):409–17.
   PubMedGoogle Scholar
• Dorfmeister B, Zeng WW, Dichlberger A . Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding. Arterioscler Thromb Vasc Biol. 2008;28(10): 1866–71.
   PubMedGoogle Scholar
• Merkel M, Heeren J. Give me A5 for lipoprotein hydrolysis! J Clin Invest. 2005;115(10):2694–6.
   PubMedGoogle Scholar
• van der Vleuten GM, Isaacs A, Zeng WW . Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia. Biochim Biophys Acta. 2007;1772(1): 81–8.
   PubMedGoogle Scholar
• Olivier M, Wang X, Cole R . Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. Genomics. 2004;83(5):912–23.
   PubMedGoogle Scholar
• Talmud PJ, Hawe E, Martin S . Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet. 2002;11(24): 3039–46.
   PubMedGoogle Scholar
• Wright WT, Young IS, Nicholls DP . SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population. Atherosclerosis. 2006;185(2):353–60.
   PubMedGoogle Scholar
• Ruiz-Narvaez EA, Yang Y, Nakanishi Y . APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica. J Lipid Res. 2005;46(12):2605–13.
   PubMedGoogle Scholar
• Waterworth DM, Jansen H, Nicaud V . Interaction between insulin (VNTR) and hepatic lipase (LIPC-514C>T) variants on the response to an oral glucose tolerance test in the EARSII group of young healthy men. Biochim Biophys Acta. 2005;1740(3):375–81.
   PubMedGoogle Scholar
• Li WW, Dammerman MM, Smith JD . Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J Clin Invest. 1995;96(6):2601–5.
   PubMedGoogle Scholar
• Travers SH, Jeffers BW, Eckel RH. Insulin resistance during puberty and future fat accumulation. J Clin Endocrinol Metab. 2002;87(8):3814–8.
   PubMedGoogle Scholar